Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Angelo DI Leo
Based on 65 articles published since 2009
(Why 65 articles?)
||||
Expertise Level
The expertise of Angelo DI Leo ranks in the
  • Top 0.035%
  • ... of 264,224 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 65 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Di Leo, Angelo   ·   DI Leo, Angelo
Work Locations
Details
Most likely:    Miscellaneous institutions in Prato      
2019
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy; Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland; Breast Unit of Southern Switzerland (CSSI), Lugano, Switzerland. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy. Electronic address: · Pubmed 30708267
2018
  • Nuovo Ospedale di Prato Santo Stefano, Prato, Italy. Electronic address: · Royal Marsden Hospital, London, UK. · National Cancer Center, Gyeonggi-do, South Korea. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Universitätsklinikum Ulm, Ulm, Germany. · University of Wisconsin-Madison, Madison, WI, USA. · Centre Jean Perrin, Clermont-Ferrand, France. · Medical University of Varna, Varna, Bulgaria. · Universität Frauenklinik Innsbruck, Innsbruck, Austria. · JNSZ Megyei Hetényi Géza Kórház-Rendelőintézet, Szolnok, Hungary. · ARNAS Garibaldi, Catania, Italy. · Onkonet-Onkologie Ravensburg, Ravensburg, Germany. · Maastricht University Medical Center+, Maastricht, Netherlands. · Rainier Hematology-Oncology/Northwest Medical Specialties, Tacoma, WA, USA. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Centre Léon Bérard, Lyon, France. · Pubmed 29223745
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Prato, Italy · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · Breast Unit of Southern Switzerland (CSSI), Lugano, Switzerland. · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Prato, Italy. · Pubmed 30061257
  • J.C. Heuson Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Department of Pathology, GZA Ziekenhuizen, Campus Sint Augustinus, Wilrijk, Belgium. · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro," Department of Clinical Sciences and Community Health, University of Milan Campus, Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Internal Medicine (DiMI), University of Genoa and IRCCS San Martino-National Cancer Institute, Genoa, Italy. · Department of Pathology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Prato, Italy. · Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK. · Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 29471435
2017
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Matthew P. Goetz, Mayo Clinic, Rochester, MN · Masakazu Toi, Kyoto University, Kyoto, Japan · Mario Campone, Institut de Cancerologie de l'Ouest, Angers Cedex · Olivier Trédan, Centre Léon Bérard, Lyon · Nawel Bourayou, Eli Lilly, Paris, France · Joohyuk Sohn, Yonsei Cancer Center, Seoul · In Hae Park, National Cancer Center, Goyangsi, South Korea · Shani Paluch-Shimon, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel · Jens Huober, University of Ulm, Ulm, Germany · Shin-Cheh Chen, Chang Gung University Medical College, Taipei, Taiwan · Luis Manso, Hospital Universitario 12 de Octubre · Susana Barriga, Eli Lilly, Madrid, Spain · Orit C. Freedman, Durham Regional Cancer Centre, Oshawa, Ontario, Canada · Georgina Garnica Jaliffe, Grupo Médico CAMINO S.C., Mexico City, Mexico · Tammy Forrester, Martin Frenzel, and Ian C. Smith, Eli Lilly, Indianapolis, IN · and Angelo Di Leo, Hospital of Prato, Prato, Italy. · Pubmed 28968163
2016
  • "Sandro Pitigliani" Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Via Suor Niccolina 20, 59100, Prato, Italy. · Magnetic Resonance Centre (CERM), University of Florence, Via L. Sacconi 6, 50019, Sesto Fiorentino, Italy. · FiorGen Foundation, Via L. Sacconi 6, 50019, Sesto Fiorentino, Italy. · Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019, Sesto Fiorentino, Italy. · "Sandro Pitigliani" Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Via Suor Niccolina 20, 59100, Prato, Italy. · Pubmed 26987537
2015
  • 'Sandro Pitigliani' Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Via Suor Niccolina 20, Prato, PO 59100, Italy. · Translational Research Laboratory, Hospital of Prato, Instituto Toscano Tumori, Via Suor Niccolina 20, Prato, PO 59100, Italy. · Pubmed 26011489
  • Centre Hospitalier Universitaire du Sart Tilman Liège and Liège University, Domaine Universitaire du Sart Tilman, B35, 4000 Liège, Belgium. Electronic address: · Centre de Recherche en Cancérologie de Lyon, Inserm U1052 CNRS 5286, Centre Léon Bérard, 28 rue Laënnec, 69373 LYON cedex 08, Lyon, France. Electronic address: · PUCRS School of Medicine, Padre Chagas 66, 203, Porto Alegre, RS 90 570 080, Brazil. Electronic address: · University Hospitals Leuven, Leuven, Belgium. Electronic address: · Hospital of Prato, Istituto Toscani Tumori, Prato, Italy. Electronic address: · Women's Hospital, University of Ulm, Prittwitzstr. 43, D-89075 Ulm, Germany. Electronic address: · Royal Melbourne Hospital, Grattan St., Parkville, Melbourne 3050, Australia. Electronic address: · Pubmed 25575443
  • Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver · Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia · Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec · Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston · Susan Dent, Ottawa Health Research Institute, Ottawa · Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto · Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario · Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada · Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia · Bella Kaufman, Sheba Medical Centre, Tel Hashomer · Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel · Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg · Sergei Tjulandin, Russian Cancer Research Center, Moscow · Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia · Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy · Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain · Lee S. Schwartzberg, West Clinic, Memphis, TN · Arnd Nusch, Praxis, Velbert, Germany · Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom · Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan · Anne P. Connor, GlaxoSmithKline, Collegeville, PA · and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil. · Pubmed 25779558
2014
  • Ann H. Partridge, Dana-Farber Cancer Institute · Steven E. Come, Beth Israel Deaconess Medical Center · Beverly Moy, Massachusetts General Hospital, Boston, MA · R. Bryan Rumble, American Society of Clinical Oncology, Alexandria · Michael A. Danso, Virginia Oncology Associates, Norfolk, VA · Lisa A. Carey, University of North Carolina, Chapel Hill, NC · Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA · Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy · Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA · Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX · Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN · Shelley B. Brundage, Patient Representative, Washington, DC · Maggie Wilcox, Independent Cancer Patients' Voice · and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom. · Pubmed 25185096
  • Affiliations of authors: "Sandra Pitigliani" Medical Oncology Unit, Hospital of Prato, Prato, Italy (ADL, LM) · Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liège University, Liège, Belgium (GJ) · Department of Oncology, First Faculty of Medicine of Charles University, Prague, Czech Republic (LP) · Clinical Oncology, Instituto Nacional del Cáncer, Santiago, Chile (RT) · Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine (INB) · Republican Clinical Oncological Center, Kazan, Russia (RK) · AZ Klina, Brasschaat, Belgium (DV) · Mastology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil (JLP) · Thoracal Department, Medical Radiological Science Center, Obninsk, Russia (IS) · Chemotherapy and Combined Therapy, Russian Cancer Research Centre, Moscow, Russia (MRL) · Medical Oncology, Kansas City Cancer Center, Kansas City, MO USA (KP) · AstraZeneca Pharmaceuticals, Macclesfield, UK (SG, YR) · Medical Oncology Service, Instituto de Investigacion Sanitaria, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (MM). · Pubmed 24317176
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
2010
  • Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Prato, Italy. · Pubmed 20855825
2013
  • Sandro Pitigliani Medical Oncology Unit, Department of Oncology, Hospital of Prato, Prato, Italy. · Pubmed 23321033
2012
Probable:    Istituto Toscano Tumori      
2018
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Centre for Magnetic Resonance (CERM), University of Florence, Via Sacconi 6, Sesto Fiorentino 50019, Italy. · Department of Mathematics, Statistics and Computer Science, Marquette University, Milawaukee, WI, USA. · Centre for Magnetic Resonance (CERM), University of Florence, Via Sacconi 6, Sesto Fiorentino 50019, Italy; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, Florence 50100, Italy. · Centre for Magnetic Resonance (CERM), University of Florence, Via Sacconi 6, Sesto Fiorentino 50019, Italy; Department of Chemistry, University of Florence, Via della Lastruccia 3, Sesto Fiorentino 50019, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · Pubmed 29775779
  • Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: · IBCSG Statistical Center and Department of Mathematics and Statistics, University of Vermont, Burlington, VT, USA. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy. · Centro di Riferimento Oncologico, Aviano, Italy. · Department of Surgical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Orsola Hospital and University of Bologna, Bologna, Italy. · Riverina Cancer Care Centre, Wagga Wagga, NSW, Australia. · Breast Center St Gallen, Kantonsspital, St Gallen, Switzerland. · Department of Medical Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · IBCSG and University of Sydney, Sydney, NSW, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · IBCSG and European Institute of Oncology, Milan, Italy. · Pubmed 30196031
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, and Harvard T.H Chan School of Public Health, Boston, MA, USA. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, Department of Oncology and Hemato-oncology, European Institute of Oncology and University of Milan, Milan, Italy. · National Institute of Oncology, Budapest, Hungary. · Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Rimini, Dipartimento di Oncologia ed Ematologia, AUSL della Romagna, Rimini, Italy. · Translational Research Coordination and Central Pathology Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan and International Breast Cancer Study Group Central Pathology Office, Milan, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, and International Breast Cancer Study Group, Prato, Italy. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School and Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Scientific & Clinical Evaluation Board, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, and International Breast Cancer Study Group, Milan, Italy. · Pubmed 29589138
  • Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: · Department of Medical Oncology, Fouad Khoury and Makassed General Hospital, Beirut, Lebanon. · Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Department of Surgery, Waikato Hospital, University of Auckland School of Health Sciences, Hamilton, New Zealand. · Swedish Breast Cancer Group and Department of Oncology, Linköping University, Linköping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain (on behalf the Grupo Español de Investigación en Cáncer de Mama). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, and Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group, Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Department of Radiation Oncology, Sir Charles Gairdner Hospital, University of Western Australia, Genesis Cancer Care, Edith Cowan University, and Breast Cancer Trials Australia & New Zealand, Perth, Australia. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · International Breast Cancer Study Group, Bern, Switzerland; Peter MacCallum Cancer Centre, Melbourne, Australia; St. Vincents's Hospital, University of Melbourne, Australia; Breast Cancer Trials Australia & New Zealand, University of Newcastle, Newcastle, Australia. · Pubmed 29534902
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · CHU Sart Tilman Liège and Liège University, Avenue de L'Hôpital 1, 4000 Liège, Belgium. Electronic address: · Instituto Nacional del Cáncer, Avda Profesor Zañartu 1010, Independencia, Santiago, Región Metropolitana, Chile. Electronic address: · University of Antwerp, Prinsstraat 13, 2000 Antwerpen, Belgium. Electronic address: · University of Kansas Cancer Center, 1000 E 101st Terrace, Kansas City, MO 64131, USA. Electronic address: · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · AstraZeneca, da Vinci Building, Melbourn Science Park, Melbourn, Royston, Herts, SG8 6HB, UK. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address: · Pubmed 29324303
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • International Breast Cancer Study Group, Milan, Italy; Division of Medical Senology, Milan, Italy. Electronic address: · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group and Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · International Breast Cancer Study Group, Australia and New Zealand Breast Cancer Trials Group, and Box Hill and Maroondah Hospitals, Monash University, Melbourne, VIC, Australia. · International Breast Cancer Study Group and Lucerne Canton Hospital, Lucerne, Switzerland. · International Breast Cancer Study Group, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium. · International Breast Cancer Study Group and Multidisciplinary Breast Center, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. · International Breast Cancer Study Group and National Institute of Oncology, Budapest, Hungary. · International Breast Cancer Study Group and Centre Hospitalier Chrétien Clinique St Joseph, Liège, Belgium. · International Breast Cancer Study Group and ASST Spedali Civili di Brescia, Brescia, Italy. · Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark. · Scottish Cancer Trials Breast Group and The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · German Breast Group, Neu-Isenburg, Germany. · SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain. · Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. · Austrian Breast & Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria. · Chilean Cooperative Group for Oncologic Research, Providencia, Santiago, Chile. · Cancer Trials Ireland and Cork University Hospital, Cork, Ireland. · International Breast Cancer Study Group and Centro di Riferimento Oncologico di Aviano, Aviano, Italy. · Medical Oncology Clinic, Institute Jules Bordet, Brussels, Belgium. · Swiss Group for Clinical Cancer Research, International Breast Cancer Study Group, and Breast Center St Gallen, St Gallen, Switzerland. · Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Central Pathology Office and University of Milan, Milan, Italy. · International Breast Cancer Study Group, Inselspital, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group and Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group, Milan, Italy; European Institute of Oncology, Milan, Italy. · Pubmed 29158011
  • Department of Clinical Oncology, IRCCS CRO Aviano - National Cancer Institute, Aviano, Italy. · Department of Medicine (DAME), University of Udine, Udine, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Division & Breast Unit, Senatore Antonio Perrino Hospital, Brindisi, Italy. · Breast Oncology Department, Istituto Nazionale Tumori "Fondazione G. Pascale", Napoli, Italy. · Department of Internal Medicine, University of Genova, Ospedale Policlinico San Martino, Genoa, Italy. · Medical Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy. · Division of Medical Oncology 2, Instituto Oncologico Veneto IRCCS, Padova, Italy. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. · Medical Oncology, Sapienza, University of Rome, and IDI-IRCCS, Rome, Italy. · Department of Clinical Oncology, IRCCS CRO Aviano - National Cancer Institute, Aviano, Italy. · Department of Medicine (DAME), University of Udine, Udine, Italy. · Pubmed 30261866
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Sandro Pitigliani Translational Research Unit, Hospital of Prato, Istituto Toscano Tumori, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Department of Life Science, Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy. · Sandro Pitigliani Translational Research Unit, Hospital of Prato, Istituto Toscano Tumori, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Bioinformatics Unit, Hospital of Prato, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Department of Medical Biotechnologies, University of Siena, Siena, Italy. · Pubmed 29564743
2017
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy. · St Vincents Hospital, 35 Victoria Parade, Fitzroy, Victoria 3065, Australia. · Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy; FiorGen Foundation, Via L. Sacconi 6, 50019, Sesto Fiorentino, Italy. · Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy; Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019, Sesto Fiorentino, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · Pubmed 28676389
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy. · FiorGen Foundation, Sesto Fiorentino, Italy. · Philippine General Hospital, Manila, Philippines. · Hospital K, Hanoi, Vietnam. · University College Hospital, Ibadan, Nigeria. · Khulna Medical College and Hospital, Khulna, Bangladesh. · The International Breast Cancer Research Foundation, Madison, Wisconsin. · Department of Chemistry, University of Florence, Sesto Fiorentino, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 28082280
2016
  • "Sandro Pitigliani" Translational Research Unit, Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · Laboratorio Nazionale CIB (LNCIB), Area Science Park, and Functional Genomics & Bioinformatics Units, Trieste, Italy. · Bioinformatics Core Facility, Centre for Integrative Biology (CIBIO), University of Trento, Trento, Italy. · Pubmed 27634906
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 59100, Prato, Italy. · Department of Experimental and Clinical Medicine, University of Florence, 50139, Florence, Italy. · Department of Clinical, Experimental and Biomedical Sciences, University of Florence, 50139, Florence, Italy. · Pubmed 27034166
  • Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney · Sarah J. Lord, University of Notre Dame · Ian Marschner, Macquarie University · Paul de Souza, University of Western Sydney, Sydney, New South Wales · Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia · Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy · Stephen Johnston, Royal Marsden Hospital, London · David Cameron, University of Edinburgh, Edinburgh, United Kingdom · Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA · Michael F. Press, University of Southern California, Los Angeles, CA · and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Pubmed 26811533
2015
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · Pubmed 26320761
  • Sandro Pitigliani Medical Oncology Department, Prato Hospital, Istituto Toscano Tumori, Prato, Italy. · Sandro Pitigliani Medical Oncology Department, Prato Hospital, Istituto Toscano Tumori, Prato, Italy. Electronic address: · Pubmed 26149888
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Magnetic Resonance Center (CERM), University of Florence, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy; FiorGen Foundation, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy. Electronic address: · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Istituto Toscano Tumori, 59100 Prato, Italy. Electronic address: · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Magnetic Resonance Center (CERM), University of Florence, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy; FiorGen Foundation, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy. Electronic address: · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Istituto Toscano Tumori, 59100 Prato, Italy. Electronic address: · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Istituto Toscano Tumori, 59100 Prato, Italy. Electronic address: · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Magnetic Resonance Center (CERM), University of Florence, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy; Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, Italy. Electronic address: · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Istituto Toscano Tumori, 59100 Prato, Italy. Electronic address: · Pubmed 25151299
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Department of Clinical, Experimental and Biomedical Sciences, University of Florence, Florence, Italy. · Department of Clinical, Experimental and Biomedical Sciences, University of Florence, Florence, Italy. Electronic address: · Pubmed 25539732
2014
  • Research Laboratory of Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary; Oncogenomic Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. · Department of Biochemistry and INSERM U944, University Rene Diderot, Paris 7, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. · Pathobiochemistry Research Group of Hungarian Academy of Sciences, Semmelweis University, Department of Medicinal Chemistry, 1444, Bp. 8, POB 260, Hungary; Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary. · Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary. · Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. · Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Division of Medical Oncology, San Raffaele - Scientific Institute, Milan, Italy. · The Breakthrough Breast Cancer Research Center, Institute of Cancer Research, London, UK. · Department of Medical Oncology, Institut National de la Santé et de la Recherche Médicale Unit U981, Institut Gustave Roussy, Villejuif, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Unit Sandro Pitigliani, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Yale Cancer Center, New Haven, CT, USA. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. Electronic address: · Pubmed 24462521
2011
  • Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 21917518
2014
  • aTranslational Research Unit b'Sandro Pitigliani' Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 25188473
2013
  • 'Sandro Pitigliani' Medical Oncology Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 24074798
  • 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 23764178
  • 'Sandro Pitigliani' Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100, Prato, Italy. · Pubmed 24106899
  • Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Prato, Italy; · Pubmed 24072219
  • From the Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 23714442
2012
  • Department of Oncology, Translational Research Unit, Hospital of Prato and Istituto Toscano Tumori, 59100, Prato, Italy. · Pubmed 22538770
  • Translational Research Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 22406214
2011
  • Sandro Pitigliani Medical Oncology Unit, Department of Oncology, Hospital ofPrato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100 Prato, Italy. · Pubmed 22015281
  • Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano, Tumori, Italy. · Pubmed 21944019
  • Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, Prato, Italy. · Pubmed 21345137
2010
  • Sandro Pitigliani Medical Oncology Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100 Prato, Italy. · Pubmed 20975745
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 65 total) written by Angelo DI Leo about Breast Neoplasms:

  • The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review. 2019
  • Metabolomics in breast cancer: A decade in review. 2018
  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. 2018
  • Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00. 2018
  • Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial. 2018
  • First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study. 2018
  • Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial. 2018
  • p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial. 2018
  • Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. 2018
  • An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project. 2018
Show List of Full Article Records
Google Searches

Learn more about Angelo DI Leo using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Prato
Istituto Toscano Tumori
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Prato
2019
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy; Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland; Breast Unit of Southern Switzerland (CSSI), Lugano, Switzerland. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy. Electronic address: · Pubmed 30708267
2018
  • Nuovo Ospedale di Prato Santo Stefano, Prato, Italy. Electronic address: · Royal Marsden Hospital, London, UK. · National Cancer Center, Gyeonggi-do, South Korea. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Universitätsklinikum Ulm, Ulm, Germany. · University of Wisconsin-Madison, Madison, WI, USA. · Centre Jean Perrin, Clermont-Ferrand, France. · Medical University of Varna, Varna, Bulgaria. · Universität Frauenklinik Innsbruck, Innsbruck, Austria. · JNSZ Megyei Hetényi Géza Kórház-Rendelőintézet, Szolnok, Hungary. · ARNAS Garibaldi, Catania, Italy. · Onkonet-Onkologie Ravensburg, Ravensburg, Germany. · Maastricht University Medical Center+, Maastricht, Netherlands. · Rainier Hematology-Oncology/Northwest Medical Specialties, Tacoma, WA, USA. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Centre Léon Bérard, Lyon, France. · Pubmed 29223745
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Prato, Italy · Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland. · Breast Unit of Southern Switzerland (CSSI), Lugano, Switzerland. · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Prato, Italy. · Pubmed 30061257
  • J.C. Heuson Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Department of Pathology, GZA Ziekenhuizen, Campus Sint Augustinus, Wilrijk, Belgium. · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro," Department of Clinical Sciences and Community Health, University of Milan Campus, Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Internal Medicine (DiMI), University of Genoa and IRCCS San Martino-National Cancer Institute, Genoa, Italy. · Department of Pathology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Prato, Italy. · Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK. · Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 29471435
2017
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Matthew P. Goetz, Mayo Clinic, Rochester, MN · Masakazu Toi, Kyoto University, Kyoto, Japan · Mario Campone, Institut de Cancerologie de l'Ouest, Angers Cedex · Olivier Trédan, Centre Léon Bérard, Lyon · Nawel Bourayou, Eli Lilly, Paris, France · Joohyuk Sohn, Yonsei Cancer Center, Seoul · In Hae Park, National Cancer Center, Goyangsi, South Korea · Shani Paluch-Shimon, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel · Jens Huober, University of Ulm, Ulm, Germany · Shin-Cheh Chen, Chang Gung University Medical College, Taipei, Taiwan · Luis Manso, Hospital Universitario 12 de Octubre · Susana Barriga, Eli Lilly, Madrid, Spain · Orit C. Freedman, Durham Regional Cancer Centre, Oshawa, Ontario, Canada · Georgina Garnica Jaliffe, Grupo Médico CAMINO S.C., Mexico City, Mexico · Tammy Forrester, Martin Frenzel, and Ian C. Smith, Eli Lilly, Indianapolis, IN · and Angelo Di Leo, Hospital of Prato, Prato, Italy. · Pubmed 28968163
2016
  • "Sandro Pitigliani" Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Via Suor Niccolina 20, 59100, Prato, Italy. · Magnetic Resonance Centre (CERM), University of Florence, Via L. Sacconi 6, 50019, Sesto Fiorentino, Italy. · FiorGen Foundation, Via L. Sacconi 6, 50019, Sesto Fiorentino, Italy. · Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019, Sesto Fiorentino, Italy. · "Sandro Pitigliani" Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Via Suor Niccolina 20, 59100, Prato, Italy. · Pubmed 26987537
2015
  • 'Sandro Pitigliani' Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Via Suor Niccolina 20, Prato, PO 59100, Italy. · Translational Research Laboratory, Hospital of Prato, Instituto Toscano Tumori, Via Suor Niccolina 20, Prato, PO 59100, Italy. · Pubmed 26011489
  • Centre Hospitalier Universitaire du Sart Tilman Liège and Liège University, Domaine Universitaire du Sart Tilman, B35, 4000 Liège, Belgium. Electronic address: · Centre de Recherche en Cancérologie de Lyon, Inserm U1052 CNRS 5286, Centre Léon Bérard, 28 rue Laënnec, 69373 LYON cedex 08, Lyon, France. Electronic address: · PUCRS School of Medicine, Padre Chagas 66, 203, Porto Alegre, RS 90 570 080, Brazil. Electronic address: · University Hospitals Leuven, Leuven, Belgium. Electronic address: · Hospital of Prato, Istituto Toscani Tumori, Prato, Italy. Electronic address: · Women's Hospital, University of Ulm, Prittwitzstr. 43, D-89075 Ulm, Germany. Electronic address: · Royal Melbourne Hospital, Grattan St., Parkville, Melbourne 3050, Australia. Electronic address: · Pubmed 25575443
  • Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver · Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia · Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec · Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston · Susan Dent, Ottawa Health Research Institute, Ottawa · Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto · Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario · Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada · Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia · Bella Kaufman, Sheba Medical Centre, Tel Hashomer · Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel · Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg · Sergei Tjulandin, Russian Cancer Research Center, Moscow · Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia · Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy · Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain · Lee S. Schwartzberg, West Clinic, Memphis, TN · Arnd Nusch, Praxis, Velbert, Germany · Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom · Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan · Anne P. Connor, GlaxoSmithKline, Collegeville, PA · and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil. · Pubmed 25779558
2014
  • Ann H. Partridge, Dana-Farber Cancer Institute · Steven E. Come, Beth Israel Deaconess Medical Center · Beverly Moy, Massachusetts General Hospital, Boston, MA · R. Bryan Rumble, American Society of Clinical Oncology, Alexandria · Michael A. Danso, Virginia Oncology Associates, Norfolk, VA · Lisa A. Carey, University of North Carolina, Chapel Hill, NC · Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA · Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy · Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA · Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX · Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN · Shelley B. Brundage, Patient Representative, Washington, DC · Maggie Wilcox, Independent Cancer Patients' Voice · and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom. · Pubmed 25185096
  • Affiliations of authors: "Sandra Pitigliani" Medical Oncology Unit, Hospital of Prato, Prato, Italy (ADL, LM) · Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liège University, Liège, Belgium (GJ) · Department of Oncology, First Faculty of Medicine of Charles University, Prague, Czech Republic (LP) · Clinical Oncology, Instituto Nacional del Cáncer, Santiago, Chile (RT) · Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine (INB) · Republican Clinical Oncological Center, Kazan, Russia (RK) · AZ Klina, Brasschaat, Belgium (DV) · Mastology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil (JLP) · Thoracal Department, Medical Radiological Science Center, Obninsk, Russia (IS) · Chemotherapy and Combined Therapy, Russian Cancer Research Centre, Moscow, Russia (MRL) · Medical Oncology, Kansas City Cancer Center, Kansas City, MO USA (KP) · AstraZeneca Pharmaceuticals, Macclesfield, UK (SG, YR) · Medical Oncology Service, Instituto de Investigacion Sanitaria, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (MM). · Pubmed 24317176
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
2010
  • Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Prato, Italy. · Pubmed 20855825
2013
  • Sandro Pitigliani Medical Oncology Unit, Department of Oncology, Hospital of Prato, Prato, Italy. · Pubmed 23321033
2012
Istituto Toscano Tumori
2018
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Centre for Magnetic Resonance (CERM), University of Florence, Via Sacconi 6, Sesto Fiorentino 50019, Italy. · Department of Mathematics, Statistics and Computer Science, Marquette University, Milawaukee, WI, USA. · Centre for Magnetic Resonance (CERM), University of Florence, Via Sacconi 6, Sesto Fiorentino 50019, Italy; Department of Clinical and Experimental Medicine, University of Florence, Largo Brambilla 3, Florence 50100, Italy. · Centre for Magnetic Resonance (CERM), University of Florence, Via Sacconi 6, Sesto Fiorentino 50019, Italy; Department of Chemistry, University of Florence, Via della Lastruccia 3, Sesto Fiorentino 50019, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · Pubmed 29775779
  • Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: · IBCSG Statistical Center and Department of Mathematics and Statistics, University of Vermont, Burlington, VT, USA. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milan, Milan, Italy. · Division of Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy. · International Breast Cancer Study Group (IBCSG) Central Pathology Office, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy. · Centro di Riferimento Oncologico, Aviano, Italy. · Department of Surgical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Orsola Hospital and University of Bologna, Bologna, Italy. · Riverina Cancer Care Centre, Wagga Wagga, NSW, Australia. · Breast Center St Gallen, Kantonsspital, St Gallen, Switzerland. · Department of Medical Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · IBCSG and University of Sydney, Sydney, NSW, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · IBCSG and European Institute of Oncology, Milan, Italy. · Pubmed 30196031
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, and Harvard T.H Chan School of Public Health, Boston, MA, USA. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, Department of Oncology and Hemato-oncology, European Institute of Oncology and University of Milan, Milan, Italy. · National Institute of Oncology, Budapest, Hungary. · Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Divisione di Oncologia, Ospedale degli Infermi, Rimini, Dipartimento di Oncologia ed Ematologia, AUSL della Romagna, Rimini, Italy. · Translational Research Coordination and Central Pathology Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan and International Breast Cancer Study Group Central Pathology Office, Milan, Italy. · Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, and International Breast Cancer Study Group, Prato, Italy. · International Breast Cancer Study Group and University of Sydney, Sydney, Australia. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School and Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Scientific & Clinical Evaluation Board, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, and International Breast Cancer Study Group, Milan, Italy. · Pubmed 29589138
  • Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: · Department of Medical Oncology, Fouad Khoury and Makassed General Hospital, Beirut, Lebanon. · Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Department of Surgery, Waikato Hospital, University of Auckland School of Health Sciences, Hamilton, New Zealand. · Swedish Breast Cancer Group and Department of Oncology, Linköping University, Linköping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain (on behalf the Grupo Español de Investigación en Cáncer de Mama). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, and Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group, Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Department of Radiation Oncology, Sir Charles Gairdner Hospital, University of Western Australia, Genesis Cancer Care, Edith Cowan University, and Breast Cancer Trials Australia & New Zealand, Perth, Australia. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · International Breast Cancer Study Group, Bern, Switzerland; Peter MacCallum Cancer Centre, Melbourne, Australia; St. Vincents's Hospital, University of Melbourne, Australia; Breast Cancer Trials Australia & New Zealand, University of Newcastle, Newcastle, Australia. · Pubmed 29534902
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · CHU Sart Tilman Liège and Liège University, Avenue de L'Hôpital 1, 4000 Liège, Belgium. Electronic address: · Instituto Nacional del Cáncer, Avda Profesor Zañartu 1010, Independencia, Santiago, Región Metropolitana, Chile. Electronic address: · University of Antwerp, Prinsstraat 13, 2000 Antwerpen, Belgium. Electronic address: · University of Kansas Cancer Center, 1000 E 101st Terrace, Kansas City, MO 64131, USA. Electronic address: · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · AstraZeneca, da Vinci Building, Melbourn Science Park, Melbourn, Royston, Herts, SG8 6HB, UK. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address: · Pubmed 29324303
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • International Breast Cancer Study Group, Milan, Italy; Division of Medical Senology, Milan, Italy. Electronic address: · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA. · International Breast Cancer Study Group and Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. · International Breast Cancer Study Group, Australia and New Zealand Breast Cancer Trials Group, and Box Hill and Maroondah Hospitals, Monash University, Melbourne, VIC, Australia. · International Breast Cancer Study Group and Lucerne Canton Hospital, Lucerne, Switzerland. · International Breast Cancer Study Group, Centre Hospitalier Universitaire de Liège, Liège University, Liège, Belgium. · International Breast Cancer Study Group and Multidisciplinary Breast Center, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium. · International Breast Cancer Study Group and National Institute of Oncology, Budapest, Hungary. · International Breast Cancer Study Group and Centre Hospitalier Chrétien Clinique St Joseph, Liège, Belgium. · International Breast Cancer Study Group and ASST Spedali Civili di Brescia, Brescia, Italy. · Danish Breast Cancer Group and Rigshospitalet, Copenhagen, Denmark. · Scottish Cancer Trials Breast Group and The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · German Breast Group, Neu-Isenburg, Germany. · SOLTI Group and Fundación Instituto Valenciano de Oncologia, Valencia, Spain. · Japan Breast Cancer Research Group and Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. · Austrian Breast & Colorectal Cancer Study Group and Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria. · Chilean Cooperative Group for Oncologic Research, Providencia, Santiago, Chile. · Cancer Trials Ireland and Cork University Hospital, Cork, Ireland. · International Breast Cancer Study Group and Centro di Riferimento Oncologico di Aviano, Aviano, Italy. · Medical Oncology Clinic, Institute Jules Bordet, Brussels, Belgium. · Swiss Group for Clinical Cancer Research, International Breast Cancer Study Group, and Breast Center St Gallen, St Gallen, Switzerland. · Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland. · International Breast Cancer Study Group Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Central Pathology Office and University of Milan, Milan, Italy. · International Breast Cancer Study Group, Inselspital, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA; Frontier Science & Technology Research Foundation, Boston, MA, USA. · International Breast Cancer Study Group and University of Sydney, Sydney, NSW, Australia. · International Breast Cancer Study Group and Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · International Breast Cancer Study Group Statistical Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · International Breast Cancer Study Group, Milan, Italy; European Institute of Oncology, Milan, Italy. · Pubmed 29158011
  • Department of Clinical Oncology, IRCCS CRO Aviano - National Cancer Institute, Aviano, Italy. · Department of Medicine (DAME), University of Udine, Udine, Italy. · Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Division & Breast Unit, Senatore Antonio Perrino Hospital, Brindisi, Italy. · Breast Oncology Department, Istituto Nazionale Tumori "Fondazione G. Pascale", Napoli, Italy. · Department of Internal Medicine, University of Genova, Ospedale Policlinico San Martino, Genoa, Italy. · Medical Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy. · Division of Medical Oncology 2, Instituto Oncologico Veneto IRCCS, Padova, Italy. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. · Medical Oncology, Sapienza, University of Rome, and IDI-IRCCS, Rome, Italy. · Department of Clinical Oncology, IRCCS CRO Aviano - National Cancer Institute, Aviano, Italy. · Department of Medicine (DAME), University of Udine, Udine, Italy. · Pubmed 30261866
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Sandro Pitigliani Translational Research Unit, Hospital of Prato, Istituto Toscano Tumori, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Department of Life Science, Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy. · Sandro Pitigliani Translational Research Unit, Hospital of Prato, Istituto Toscano Tumori, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Bioinformatics Unit, Hospital of Prato, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, via Suor Niccolina Infermiera 20, 59100, Prato, Italy. · Department of Medical Biotechnologies, University of Siena, Siena, Italy. · Pubmed 29564743
2017
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy. · St Vincents Hospital, 35 Victoria Parade, Fitzroy, Victoria 3065, Australia. · Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy; FiorGen Foundation, Via L. Sacconi 6, 50019, Sesto Fiorentino, Italy. · Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy; Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019, Sesto Fiorentino, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · Pubmed 28676389
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy. · FiorGen Foundation, Sesto Fiorentino, Italy. · Philippine General Hospital, Manila, Philippines. · Hospital K, Hanoi, Vietnam. · University College Hospital, Ibadan, Nigeria. · Khulna Medical College and Hospital, Khulna, Bangladesh. · The International Breast Cancer Research Foundation, Madison, Wisconsin. · Department of Chemistry, University of Florence, Sesto Fiorentino, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 28082280
2016
  • "Sandro Pitigliani" Translational Research Unit, Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy. · Laboratorio Nazionale CIB (LNCIB), Area Science Park, and Functional Genomics & Bioinformatics Units, Trieste, Italy. · Bioinformatics Core Facility, Centre for Integrative Biology (CIBIO), University of Trento, Trento, Italy. · Pubmed 27634906
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 59100, Prato, Italy. · Department of Experimental and Clinical Medicine, University of Florence, 50139, Florence, Italy. · Department of Clinical, Experimental and Biomedical Sciences, University of Florence, 50139, Florence, Italy. · Pubmed 27034166
  • Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney · Sarah J. Lord, University of Notre Dame · Ian Marschner, Macquarie University · Paul de Souza, University of Western Sydney, Sydney, New South Wales · Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia · Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy · Stephen Johnston, Royal Marsden Hospital, London · David Cameron, University of Edinburgh, Edinburgh, United Kingdom · Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA · Michael F. Press, University of Southern California, Los Angeles, CA · and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Pubmed 26811533
2015
  • "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · Pubmed 26320761
  • Sandro Pitigliani Medical Oncology Department, Prato Hospital, Istituto Toscano Tumori, Prato, Italy. · Sandro Pitigliani Medical Oncology Department, Prato Hospital, Istituto Toscano Tumori, Prato, Italy. Electronic address: · Pubmed 26149888
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Magnetic Resonance Center (CERM), University of Florence, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy; FiorGen Foundation, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy. Electronic address: · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Istituto Toscano Tumori, 59100 Prato, Italy. Electronic address: · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Magnetic Resonance Center (CERM), University of Florence, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy; FiorGen Foundation, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy. Electronic address: · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Istituto Toscano Tumori, 59100 Prato, Italy. Electronic address: · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Istituto Toscano Tumori, 59100 Prato, Italy. Electronic address: · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Magnetic Resonance Center (CERM), University of Florence, Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy; Department of Chemistry, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, Italy. Electronic address: · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Istituto Toscano Tumori, 59100 Prato, Italy. Electronic address: · Pubmed 25151299
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Department of Clinical, Experimental and Biomedical Sciences, University of Florence, Florence, Italy. · Department of Clinical, Experimental and Biomedical Sciences, University of Florence, Florence, Italy. Electronic address: · Pubmed 25539732
2014
  • Research Laboratory of Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary; Oncogenomic Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. · Department of Biochemistry and INSERM U944, University Rene Diderot, Paris 7, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. · Pathobiochemistry Research Group of Hungarian Academy of Sciences, Semmelweis University, Department of Medicinal Chemistry, 1444, Bp. 8, POB 260, Hungary; Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary. · Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary. · Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. · Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Division of Medical Oncology, San Raffaele - Scientific Institute, Milan, Italy. · The Breakthrough Breast Cancer Research Center, Institute of Cancer Research, London, UK. · Department of Medical Oncology, Institut National de la Santé et de la Recherche Médicale Unit U981, Institut Gustave Roussy, Villejuif, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Unit Sandro Pitigliani, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Yale Cancer Center, New Haven, CT, USA. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. Electronic address: · Pubmed 24462521
2011
  • Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 21917518
2014
  • aTranslational Research Unit b'Sandro Pitigliani' Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 25188473
2013
  • 'Sandro Pitigliani' Medical Oncology Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 24074798
  • 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 23764178
  • 'Sandro Pitigliani' Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100, Prato, Italy. · Pubmed 24106899
  • Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Prato, Italy; · Pubmed 24072219
  • From the Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 23714442
2012
  • Department of Oncology, Translational Research Unit, Hospital of Prato and Istituto Toscano Tumori, 59100, Prato, Italy. · Pubmed 22538770
  • Translational Research Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Pubmed 22406214
2011
  • Sandro Pitigliani Medical Oncology Unit, Department of Oncology, Hospital ofPrato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100 Prato, Italy. · Pubmed 22015281
  • Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano, Tumori, Italy. · Pubmed 21944019
  • Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, Prato, Italy. · Pubmed 21345137
2010
  • Sandro Pitigliani Medical Oncology Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100 Prato, Italy. · Pubmed 20975745
39 Other Locations Show
Yearly article counts 1134411798620
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.